Elevated pulse amplification in hypertensive patients with advanced kidney disease

Area of Science:

• Nephrology
• Cardiology
• Hypertension

Background:

• Chronic kidney disease (CKD) progression is known to alter arterial stiffness.
• Central hemodynamic pressure profiles in CKD patients remain incompletely understood.
• Assessing these profiles is crucial for understanding cardiovascular risk in CKD.

Purpose of the Study:

• To investigate the relationship between chronic kidney disease (CKD) stage and central hemodynamic pressure profiles.
• To examine how arterial stiffness and pulse pressure change with CKD progression.
• To determine the predictive value of hemodynamic parameters for left ventricular hypertrophy (LVH) in CKD.

Main Methods:

• A cross-sectional study of 2020 hypertensive patients with varying CKD stages.
• Echocardiography and serum creatinine levels were used for patient assessment.
• Radial tonometry measured central blood pressure; patients were staged by estimated glomerular filtration rate.

Main Results:

• Central and brachial pulse pressures elevated in CKD stages 3a and 3b, respectively.
• Left ventricular mass index increased in later CKD stages (3b-5).
• Pulse amplification (PA) was lowest in early CKD (3a-3b) but inverted in advanced stages (4-5).

Conclusions:

• Cardiovascular risk is elevated in CKD stages 3b and beyond.
• Inverted PA in advanced CKD stages suggests aortic stiffening.
• Reduced ability of central pulse pressure to predict LVH in later CKD stages warrants further investigation.